Author:
Ushiroda Kantaro,Maruta Katsunori,Kitoh Makoto,Iwai Kiyotaka,Nagamine Jun,Tsuchida Atsushi,Taiji Mutsuo,Nagata Ryu
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference35 articles.
1. World Health Organization, Fact Sheet No. 138, April 2002. (http://www.who.int/mediacentre/factsheets/fs138/en).
2. Revealing the cost of Type II diabetes in Europe
3. Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
4. Current Therapies and Emerging Targets for the Treatment of Diabetes
5. (2R)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献